These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 9758314

  • 1. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ, Spinler SA.
    Pharmacotherapy; 1998; 18(5):1041-52. PubMed ID: 9758314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.
    Meune C, Mourad JJ, Bergmann JF, Spaulding C.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):149-54. PubMed ID: 14608518
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin converting enzyme inhibitors and the cardiovascular system.
    Dzau VJ.
    J Hypertens Suppl; 1992 Jun; 10(3):S3-10. PubMed ID: 1386105
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B.
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [Abstract] [Full Text] [Related]

  • 12. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA, Ghali WA, Gong Y, Fang J, Armstrong PW, Tu JV.
    Circulation; 2006 Jun 06; 113(22):2572-8. PubMed ID: 16735672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
    de Groote P, Aumégeat V, Meurice T, Millaire A, Lamblin N, Lablanche JM.
    Arch Mal Coeur Vaiss; 2000 Feb 06; 93(2):167-71. PubMed ID: 10830093
    [Abstract] [Full Text] [Related]

  • 15. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations.
    Mancini GB.
    Clin Invest Med; 2000 Apr 06; 23(2):144-61. PubMed ID: 10852664
    [Abstract] [Full Text] [Related]

  • 16. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 Apr 06; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 17. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
    Burnier M, Brunner HR.
    Therapie; 1998 Apr 06; 53(3):279-84. PubMed ID: 9773127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [ACE inhibitors and their clinical significance].
    Brunner HR, Waeber B, Nussberger J.
    Herz; 1987 Dec 06; 12 Suppl 1():3-9. PubMed ID: 3325394
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.